Search for Video Filter by category
Date Added Most Popular
All Videos Educational Technical Support Products Customer
For all you seek. Illumina.

1004 views | 1 decade ago

At Illumina, we understand that as a researcher you are unique, and that your research is too. We feel the same way about our company and products. But we all have one thing in common, our drive to...

What is Phasing?

5976 views | 1 decade ago

Whole-genome sequencing conventionally generates a single consensus sequence without distinguishing between variants on homologous chromosomes. Genome phasing addresses this limitation by separating...

Illumina's team of driven individuals makes a difference in the world

11047 views | 1 decade ago

At Illumina, we work on game-changing technologies that benefit human health. Our work contributes to important questions like: "Why is a person more likely to develop Type-2 diabetes?" or "Why do some...

Sequencing analysis of cancer tissue samples: FFPE vs.Fresh Frozen

2218 views | 1 decade ago

Illumina Cancer Webinar Series: Gad Getz, Ph.D., founder of the Cancer Genome Computational Analysis group at the Broad Institute and Director of Bioinformatics at the Mass General Cancer Center and...

Advances in Genome Science: Illumina AACR Discovery Symposium

702 views | 1 decade ago

Mark Van Oene, Vice President of Global Sales at Illumina, discusses the company's development of market-specific products and solutions for cancer and genetic disease.

Illumina-Based Sequencing for Early Detection of Ovarian and Endometrial Malignancies with Luis Diaz

488 views | 1 decade ago

Luis Diaz, MD, Associate Professor of Oncology at Ludwig Center for Cancer Genetics and Therapeutics at Johns Hopkins, discusses the application of genomic information in a clinical manner.

Tumor Evolution in the Transcriptome, Epigenome, and Epitranscriptome

1169 views | 1 decade ago

Christopher Mason, Assistant Professor in the Department of Physiology and Biomedicine at the Weill Cornell Medical College, describes how tumor evolution can be tracked by sequencing the transcriptome,...

Illumina's Genomic Technologies: Applications in Cancer Research and Translation

484 views | 1 decade ago

Jennifer Stone, Ph.D., Cancer Genomics Market Manager at Illumina, discusses Illumina's view of cancer research and how by continually advancing its technologies it is supporting researchers with tools...

For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see www.illumina.com/company/legal.html.

© 2024 Illumina, Inc. All rights reserved.